COURTNEY RAINWATER: Open Payments
NPI 1962136929 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 28 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $752 · 2025 $957
Food & beverage: $939Education: $18
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $156 |
| Medtronic, Inc. | 2 | $126 |
| Edwards Lifesciences Corporation | 1 | $126 |
| Alnylam Pharmaceuticals Inc. | 3 | $102 |
| Amgen Inc. | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| HEARTFLOW, INC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $33 |
Products named: XIENCE SKYPOINT, LINQ II, AMVUTTRA, Repatha, LEQVIO, ELIQUIS, CAMZYOS, FFRct.
Industry payments across CO — which companies pay providers there.
